Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.4 EUR | 0.00% | -2.36% | +13.76% |
May. 02 | Magis announces warrant exercise ratio for May | AN |
Mar. 26 | Magis improves profit in 2023; revenues down 14 percent | AN |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.65 for the 2023 fiscal year.
- The company has a low valuation given the cash flows generated by its activity.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.76% | 61M | - | ||
+14.47% | 35.28B | B+ | ||
-4.67% | 4.2B | B+ | ||
+16.36% | 1.46B | D | ||
-9.16% | 1.27B | - | - | |
+21.89% | 1.25B | - | - | |
-23.26% | 794M | - | ||
-29.14% | 714M | - | - | |
-21.26% | 707M | - | ||
-15.47% | 655M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MGS Stock
- Ratings Magis S.p.A.